Showing results (141-150 of 276) with videos related to
Sort By:
Pageof 28
Journal of Virology|June 8, 2007
Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibitionPatricia M Day, Cynthia D Thompson, Christopher B Buck, et al.Cancer Immunology Research|April 15, 2021
Virus-Like Particle-Drug Conjugates Induce Protective, Long-lasting Adaptive Antitumor Immunity in the Absence of Specifically Targeted Tumor AntigensRhonda C Kines, Cynthia D Thompson, Sean Spring, et al.Cell Host & Microbe|September 14, 2010
In vivo mechanisms of vaccine-induced protection against HPV infectionPatricia M Day, Rhonda C Kines, Cynthia D Thompson, et al.The Journal of Infectious Diseases|June 1, 1996
Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behaviorJ Dillner, I Kallings, C Brihmer, et al.Journal of Virology|October 3, 2001
Positively charged termini of the L2 minor capsid protein are necessary for papillomavirus infectionR B Roden, P M Day, B K Bronzo, et al.Journal of Virology|March 28, 2008
Arrangement of L2 within the papillomavirus capsidChristopher B Buck, Naiqian Cheng, Cynthia D Thompson, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 21, 2001
Papillomavirus-like particles induce acute activation of dendritic cellsP Lenz, P M Day, Y Y Pang, et al.Cancer Discovery|April 17, 2023
Opportunities for Achieving the Cancer Moonshot Goal of a 50% Reduction in Cancer Mortality by 2047Meredith S Shiels, Stanley Lipkowitz, Nicole G Campos, et al.Vaccine|August 2, 2011
Expression of codon optimized major capsid protein (L1) of human papillomavirus type 16 and 18 in Pichia pastoris; purification and characterization of the virus-like particlesN Hanumantha Rao, P Baji Babu, L Rajendra, et al.The Lancet. Infectious Diseases|May 27, 2009
Clinician's guide to human papillomavirus immunology: knowns and unknownsMark H Einstein, John T Schiller, Raphael P Viscidi, et al.Pageof 28